Your Lab Lost Its Federal Grant. These Universities Are Writing Emergency Checks to Keep Science Alive.

The email from NIH arrives on a Tuesday afternoon: your grant has been terminated. The five-year R01 that funds your postdoc, two graduate students, and a technician — the grant that underwrites reagents, sequencing runs, and the manuscript you were weeks from submitting — is gone. Not deferred. Not reduced. Terminated.

This scenario has played out thousands of times since early 2025. The NIH awarded 24 percent fewer R01s last year — 1,319 fewer awards than the historical average. NSF terminated 1,752 grants worth $1.4 billion. And the downstream damage compounds: over 2,200 NIH grants totaling $3.8 billion have been canceled, while an additional $1.7 billion sits in administrative limbo. For PIs on the receiving end, the question is immediate and existential: how do I keep my lab open next month?

A growing number of universities have answered that question with their own checkbooks.

The Endowment Lifeline

Johns Hopkins University moved first and moved big. In spring 2025, the university announced it would tap earnings from its $13.2 billion endowment to fund direct relief: $100,000 per researcher for grants that were delayed, or $150,000 for grants that were terminated, disbursed over a 12-month period. The logic was straightforward — keeping experienced researchers intact is cheaper than rebuilding labs from scratch once federal funding eventually resumes.

Yale followed with a two-pronged approach. The School of Medicine began offering bridge funding to faculty whose grants were terminated, with particular attention to researchers working on topics the Trump administration flagged as low priority, including transgender health and DEI-related science. Separately, Yale's Graduate School of Arts and Sciences committed $4 million specifically to support graduate students who lost training and research grants. The distinction matters: bridge funding for PIs protects labs, but graduate student funding protects an entire generation of scientists in training.

Northwestern University took a more modest but still significant step, offering faculty up to $50,000 to maintain projects for up to one year. The university had additional reason for urgency — it reportedly had not received NIH payments since March 2026, creating a cash-flow crisis that affected even researchers whose grants had not been formally terminated.

The University of Arizona established a $1 million Bridge Funding Investment Program with a specific triage hierarchy: Ph.D. student support first, then faculty with established funding track records. The Universities of Hawaii and Massachusetts launched similar programs. UConn created an Emergency Research Grant Expenditure Fund in spring 2025 that had distributed $1.6 million across 12 awards by October, prioritizing the prevention of layoffs and protection of graduate students approaching degree completion.

What Bridge Funding Actually Covers — and What It Does Not

The programs share a common structure: temporary, limited funding to prevent irreversible damage — lab closures, personnel layoffs, abandoned experiments — while PIs seek alternative support. But they are not replacement grants. Johns Hopkins's $150,000 ceiling is generous for bridge funding but represents a fraction of a typical R01's annual direct costs. Northwestern's $50,000 might cover a technician's salary for a year or keep a mouse colony alive, but it will not fund a new clinical trial.

This is by design. Bridge funding is triage, not treatment. It buys time for researchers to resubmit proposals, pivot to different agencies, or pursue foundation and industry partnerships. The universities making these investments are betting that the federal funding landscape will stabilize — that Congress will continue rejecting the most severe proposed cuts, as it did for FY2026, and that agencies will eventually resume normal award cycles.

That bet is not unreasonable. Congress rejected the White House's proposed 55 percent cut to NSF, restored NASA's science missions, and boosted DOE's Office of Science budget by 2 percent in the FY2026 appropriations. But the FY2027 budget request, released April 3, proposes cutting NSF by another 54.5 percent, NIH by $5 billion, and EPA by 52 percent — numbers that set the negotiating anchor even if Congress ultimately rejects them. Bridge funding works when the bridge leads somewhere. If the cuts deepen, universities will exhaust their reserves.

The Uneven Geography of Survival

Not every university can write emergency checks. Johns Hopkins's $13.2 billion endowment generates enough annual income to fund researcher relief without touching principal. Yale's $41 billion endowment makes $4 million for graduate students a rounding error. These are institutions that can afford to self-insure against federal funding disruptions.

But the majority of American research does not happen at the wealthiest universities. UConn, which lost $95 million in federal funding — $41 million from terminated grants and $54 million in reduced new awards — has over 1,700 faculty, staff, and graduate assistants with salaries partially funded by federal programs. Its $1.6 million emergency fund, while meaningful, covers a tiny fraction of the shortfall. An additional $34 million in annual losses is projected if the 15 percent indirect cost rate cap takes effect.

Regional universities, HBCUs, tribal colleges, and institutions in EPSCoR states face the starkest version of this equation. They lack large endowments, they depend more heavily on federal grants as a percentage of research revenue, and they serve the populations that benefit most from federally funded science. When bridge funding is available only at elite institutions, the crisis does not just threaten individual labs — it accelerates the geographic and institutional concentration of American research.

The Association of American Universities has been clear-eyed about this asymmetry. Toby Smith, AAU's vice president for policy, put it directly: "When it comes to supporting curiosity-driven scientific research, there is simply no replacement for the federal government." Industry funds just 6.8 percent of U.S. research expenditures. Philanthropic giving, while growing at 4.2 percent annually, cannot scale to fill a $163 billion discretionary spending gap.

What Researchers Should Do Right Now

If you are a PI who has lost or may lose federal funding, the calculus has shifted. Understanding your institution's bridge funding policies is now as important as understanding your program officer's priorities.

Check whether your university has a bridge program. Many have launched them without broad publicity. Contact your office of research or vice provost for research — several institutions have created ad hoc task forces that operate below the radar. UConn's Emergency Research Grant Expenditure Fund, for example, was not widely advertised but has been accepting applications since spring 2025.

Prioritize personnel retention in your application. Every bridge program reviewed for this analysis prioritizes preventing layoffs and protecting graduate students over equipment purchases or new experiments. Frame your request around people, not projects.

Diversify your submission pipeline immediately. Bridge funding buys 6 to 12 months. Use that time to submit to DOD, DOE, DARPA, or foundation funders where your work might fit. The SBIR/STTR program, which was signed into law today after a six-month lapse, will begin publishing new solicitations from DOD, NIH, and NSF in late April through May — small businesses with prior Phase II awards should watch for the new Strategic Breakthrough Awards offering up to $30 million.

Build or strengthen industry partnerships. Stephen Susalka, CEO of AUTM, has warned that reduced federal funding constrains the innovation pipeline — but industry partners have their own incentive to keep university research alive. Sponsored research agreements, licensing deals, and joint ventures can supplement grant income while bridge funding covers the gap.

Consider the timeline honestly. Christopher Newfield of UC Santa Barbara projects the U.S. could fall behind Europe and East Asia within five years if current trends persist. If your institution lacks bridge funding and your agency's outlook is poor, the European Research Council's increased recruitment of American scientists — applications from U.S. researchers nearly tripled from 60 in 2024 to 169 in 2026 — represents a real alternative, not just a theoretical one.

The Experiment No One Wanted

University bridge funding is an emergency measure being tested in real time, without controls or precedent at this scale. The programs are creative, they are necessary, and they are saving careers that would otherwise end prematurely. But they are also a symptom of a system in which the world's largest funder of basic research has become unreliable — and in which the burden of maintaining American science is shifting, unevenly, to institutions that were never designed to bear it.

For researchers navigating this landscape, the strategic imperative is clear: secure bridge funding where available, diversify your portfolio aggressively, and treat every month of stability as time to build the next grant. Tools like Granted can help you identify alternative funding sources and move from concept to submission before the bridge runs out.